Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction

María T. Pérez-Martínez,Javier Lacunza Ruiz,Juan García-de-Lara,José A. Noguera-Velasco,Antonio Lax,Álvaro Hernández-Vicente,Mari C. Asensio-López,James L. Januzzi,Borja Ibanez,Domingo A. Pascual-Figal

Noncardiac Production of Soluble ST2 in ST-Segment Elevation Myocardial Infarction

2018

María T. Pérez-Martínez
Javier Lacunza Ruiz
Juan García-de-Lara
José A. Noguera-Velasco
Antonio Lax
Álvaro Hernández-Vicente
Mari C. Asensio-López
James L. Januzzi
Borja Ibanez
Domingo A. Pascual-Figal

The soluble isoform of ST2 (sST2) represents a powerful prognostic biomarker in patients with heart failure and acute coronary syndromes. In patients with ST-segment elevation myocardial infarction (STEMI), concentrations of sST2 are elevated early and identify a higher risk of death, adverse

Keywords:

Elevation
ST segment
Myocardial infarction
Heart failure
Biomarker (medicine)
Diabetes mellitus
Internal medicine
Cardiology
Medicine
in patient
prognostic biomarker
risk of death

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations